Melinda represents Fortune 200 companies and classes of direct and indirect purchasers of products that have been the subject of antitrust violations across the globe. She has litigated complex class actions through the hurdles of class certification, summary judgment, and trial. In her cases, clients and classes she represents have obtained more than $1 billion in settlements, and in one recent case, a 9-0 victory in the U.S. Supreme Court. She proudly works to ensure private enforcement of the country’s antitrust laws and to ensure free and open markets.
65
On March 28, 2019, the Federal Trade Commission (the “Commission”) issued a landmark opinion in the agency’s case against Impax Laboratories Inc. regarding its patent settlement with Endo Pharmaceuticals Inc., marking the first time that the Commission has weighed in on the proper application of (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 144
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
